BNIP3 and breast carcinoma: In cisplatin‐resistant breast cancer cell line MCF‐7/R, BNIP3 expression was down‐regulated by miR‐944, and inhibition of miR‐944 restored cisplatin sensitivity of MCF7/R [26].